AbbVie said today it would buy Botox-maker Allergan in a cash-and-stock deal for about $63 billion to add fast-growing therapeutic businesses such as medical aesthetics and eye care.
AbbVie to buy Botox-maker Allergan in a $63B cash-and-stock deal
Source: CNBC
Business Events
Health Care Update Webinar
Wednesday, May 25, 2022
Highmark Webinar
Wednesday, June 08, 2022
Security. Technology, Security, Hybrid and Remote Workers
Wednesday, June 29, 2022
Women of Influence
Thursday, June 30, 2022
